Status:

COMPLETED

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

Lead Sponsor:

Rebiscan, Inc.

Collaborating Sponsors:

Vanderbilt University

Conditions:

Amblyopia

Strabismus

Eligibility:

All Genders

3-8 years

Brief Summary

The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and ...

Eligibility Criteria

Inclusion

  • Children aged 3-8 years
  • Signed Informed consent by parent or guardian
  • Meet all inclusion criteria.

Exclusion

  • Children with a history of developmental delay or cognitive deficit
  • Children unable to complete the GSE (including visual acuity testing)

Key Trial Info

Start Date :

December 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2012

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT01832883

Start Date

December 1 2010

End Date

July 1 2012

Last Update

April 13 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt Eye Institute

Nashville, Tennessee, United States, 37232